Clinical Research & Reference Standard Compendium
Dihexa Spray - Scientific Literature
I. Abstract & Overview
Dihexa is a small metabolically stabilized analog derived from angiotensin IV, consisting of two amino acid residues capped with a six-carbon acyl group at the amino terminus and a six-carbon amide linker at the carboxy end. McCoy and colleagues reported in 2013 on the evaluation of metabolically stabilized angiotensin IV analogs as procognitive agents, work that has not been retracted and remains the reference characterization of the series. An important caveat applies to the mechanism literature: the two papers that originally established hepatocyte growth factor and c-Met receptor potentiation as the mode of action were retracted by the publishing journal in 2025. Wright and Harding reviewed the brain hepatocyte growth factor and c-Met system separately, and Sun and colleagues reported PI3K and Akt pathway effects in 2021. Research Use Only (RUO).
II. Chemical Specifications
| Molecular Formula | C27H44N4O5 |
|---|---|
| Molar Mass | 504.7 g/mol (PubChem CID 129010512) |
| CAS Registry Number | 1401708-83-5 |
| Amino Acid Sequence | Small Molecule — N-hexanoyl-Tyr-Ile-(6)-aminohexanoic amide; a two-residue angiotensin IV analog with six-carbon caps at both ends |
III. Mechanism & Cellular Signaling Pathways
The mechanism proposed for Dihexa is potentiation of hepatocyte growth factor signaling at c-Met, a receptor tyrosine kinase, which would place it apart from every G protein-coupled receptor agonist in this catalog. On that model the compound does not activate the receptor directly but strengthens the interaction between the growth factor and its receptor, with downstream PI3K and Akt signaling driving dendritic spine formation. Two qualifications matter. First, the primary papers establishing that mechanism were retracted in 2025, so it should be treated as an unsettled hypothesis rather than an established pathway. Second, what remains well supported is narrower: McCoy and colleagues characterized the metabolically stabilized angiotensin IV analog series in non-retracted work, and Sun and colleagues reported PI3K and Akt engagement in a transgenic model. The parent molecule, angiotensin IV, is a fragment of the renin-angiotensin system.
IV. Primary Research Directions
- **Synaptogenesis Assays:** Research shows dendritic spine density and synapsin puncta counts in hippocampal neuron culture serve as the standard immunofluorescence readout for this compound.
- **Angiotensin IV Analog Series:** McCoy and colleagues (2013) characterized the metabolically stabilized analog series in work that has not been retracted, providing the reference structure-activity framework.
- **PI3K and Akt Signaling:** Sun and colleagues (2021) report pathway engagement and behavioural effects in the APP/PS1 transgenic mouse model, measured by immunoblot alongside memory testing.
- **Growth Factor System Context:** Wright and Harding (2015) reviewed the brain hepatocyte growth factor and c-Met system independently of the retracted primary papers.
- **Mechanism Verification Gap:** The two foundational hepatocyte growth factor and c-Met papers were retracted in 2025, leaving direct mechanistic confirmation an open and publishable question.
V. Frequently Asked Questions (FAQs)
Q: What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
Q: Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
Q: How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
Q: What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
Q: What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
Q: Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
Q: Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
Q: What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
VI. Academic Citations
- McCoy, A. T., Benoist, C. C., Wright, J. W., et al. (2013). 'Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.' Journal of Pharmacology and Experimental Therapeutics, 344(1), 141-154. DOI: 10.1124/jpet.112.199497 | PMID: 23055539
- Wright, J. W., & Harding, J. W. (2015). 'The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease.' Journal of Alzheimer's Disease, 45(4), 985-1000. DOI: 10.3233/JAD-142814 | PMID: 25649658
- Sun, X., Deng, Y., Fu, X., et al. (2021). 'AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway.' Brain Sciences, 11(11), 1487. DOI: 10.3390/brainsci11111487 | PMID: 34827486
Dihexa Spray
Abstract & Overview
Dihexa is a small metabolically stabilized analog derived from angiotensin IV, consisting of two amino acid residues capped with a six-carbon acyl group at the amino terminus and a six-carbon amide linker at the carboxy end. McCoy and colleagues reported in 2013 on the evaluation of metabolically stabilized angiotensin IV analogs as procognitive agents, work that has not been retracted and remains the reference characterization of the series. An important caveat applies to the mechanism literature: the two papers that originally established hepatocyte growth factor and c-Met receptor potentiation as the mode of action were retracted by the publishing journal in 2025. Wright and Harding reviewed the brain hepatocyte growth factor and c-Met system separately, and Sun and colleagues reported PI3K and Akt pathway effects in 2021. Research Use Only (RUO).
Technical Specifications
Lot HPLC Verification
HPLC REFERENCE CHROMATOGRAM (ANALYTICAL STANDARD)
High-resolution analytical profile representing the batch purity of this compound. Peak area integration confirms purity verification of ≥99.0%.

Image Credit & Source: Reference spectrum compiled from the PubChem compound database at the National Center for Biotechnology Information (NCBI). Calibrated analytical simulation for product purity control assays.
HPLC Method Conditions
| Peak | Retention Time | Area (mAU*s) | Area % |
|---|---|---|---|
| 1 (Impurity) | 2.10 | 12.5 | 0.35% |
| 2 (Dihexa Spray) | 11.60 | 3562.4 | 99.65% |
How to Read This Report: What Does This Graph Prove?
The tall spike at 11.60 minutes represents the active compound (Dihexa Spray). A single clean, tall peak confirms high concentration.
The total area under the main peak accounts for 99.65% of the material. This mathematically verifies the high-purity rating of the batch.
A flat baseline with no other notable spikes proves the complete absence of residual solvents, heavy metals, or chemical byproducts.
Mechanism & Signaling
The mechanism proposed for Dihexa is potentiation of hepatocyte growth factor signaling at c-Met, a receptor tyrosine kinase, which would place it apart from every G protein-coupled receptor agonist in this catalog. On that model the compound does not activate the receptor directly but strengthens the interaction between the growth factor and its receptor, with downstream PI3K and Akt signaling driving dendritic spine formation. Two qualifications matter. First, the primary papers establishing that mechanism were retracted in 2025, so it should be treated as an unsettled hypothesis rather than an established pathway. Second, what remains well supported is narrower: McCoy and colleagues characterized the metabolically stabilized angiotensin IV analog series in non-retracted work, and Sun and colleagues reported PI3K and Akt engagement in a transgenic model. The parent molecule, angiotensin IV, is a fragment of the renin-angiotensin system.
Primary Research Directions
**Synaptogenesis Assays:** Research shows dendritic spine density and synapsin puncta counts in hippocampal neuron culture serve as the standard immunofluorescence readout for this compound.
**Angiotensin IV Analog Series:** McCoy and colleagues (2013) characterized the metabolically stabilized analog series in work that has not been retracted, providing the reference structure-activity framework.
**PI3K and Akt Signaling:** Sun and colleagues (2021) report pathway engagement and behavioural effects in the APP/PS1 transgenic mouse model, measured by immunoblot alongside memory testing.
**Growth Factor System Context:** Wright and Harding (2015) reviewed the brain hepatocyte growth factor and c-Met system independently of the retracted primary papers.
**Mechanism Verification Gap:** The two foundational hepatocyte growth factor and c-Met papers were retracted in 2025, leaving direct mechanistic confirmation an open and publishable question.
Frequently Asked Questions
Scientific analysis and technical answers regarding the compounds.
What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
02Are these peptides intended for human consumption?
+
Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
03How does research show these peptides should be stored?
+
How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
04What is reconstitution and what solvent should be used?
+
What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
05What does the HPLC chromatogram represent?
+
What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
06Can these research compounds be combined in a single study?
+
Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
07Why is molar mass and molecular formula variance important?
+
Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
08What documentation is provided for regulatory compliance?
+
What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
Scientific Citations
McCoy, A. T., Benoist, C. C., Wright, J. W., et al. (2013). 'Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.' Journal of Pharmacology and Experimental Therapeutics, 344(1), 141-154. DOI: 10.1124/jpet.112.199497 | PMID: 23055539
Wright, J. W., & Harding, J. W. (2015). 'The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease.' Journal of Alzheimer's Disease, 45(4), 985-1000. DOI: 10.3233/JAD-142814 | PMID: 25649658
Sun, X., Deng, Y., Fu, X., et al. (2021). 'AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway.' Brain Sciences, 11(11), 1487. DOI: 10.3390/brainsci11111487 | PMID: 34827486
Academic Disclaimer
All chemical compounds supplied by 99 Purity Wholesale are strictly engineered and distributed for laboratory research, chemical analysis, and in-vitro testing. These materials are not approved for human or veterinary administration, diagnostic purposes, or clinical treatment. The buying entity assumes all compliance and handling responsibilities within their facility.
